IMIPENEM AND CILASTATIN

IMIPENEM AND CILASTATIN was reported 4099 times

IMIPENEM AND CILASTATIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ARTERIOVENOUS GRAFT SITE COMPLICATION 2 0.2857
1 ATOPIC COUGH 1 0.2500
2 DOLICHOCEPHALY 1 0.2500
3 BIFIDOBACTERIUM INFECTION 4 0.1481
4 SECONDARY THROMBOCYTOSIS 2 0.1053
5 RED BLOOD CELL ROULEAUX FORMATION PRESENT 2 0.1000
6 IMPETIGO HERPETIFORMIS 3 0.0811
7 GRANULICATELLA BACTERAEMIA 1 0.0556
8 HYALOSIS ASTEROID 2 0.0488
9 MYCOBACTERIAL PERITONITIS 4 0.0421
10 ACUTE HAEMOLYTIC TRANSFUSION REACTION 1 0.0357
11 DIFFUSE CUTANEOUS MASTOCYTOSIS 1 0.0333
12 PERITONEAL EFFLUENT LEUKOCYTE COUNT INCREASED 2 0.0317
13 MYCOBACTERIUM ABSCESSUS INFECTION 21 0.0294
14 SLEEP PHASE RHYTHM DISTURBANCE 4 0.0267
15 DRUG TROUGH LEVEL 1 0.0244
16 AUDITORY NERVE DISORDER 1 0.0227
17 INTERVERTEBRAL DISC CALCIFICATION 2 0.0220
18 DISSEMINATED NOCARDIOSIS 3 0.0216
19 DIPHTHERIA 1 0.0213
20 CERVIX ENLARGEMENT 1 0.0204
21 EYELID MYOCLONUS 2 0.0200
22 DENERVATION ATROPHY 1 0.0182
23 PERONEAL NERVE INJURY 2 0.0177
24 FORCED EXPIRATORY VOLUME INCREASED 1 0.0169
25 RESPIRATORY GAS EXCHANGE DISORDER 6 0.0162
26 BACTEROIDES INFECTION 4 0.0153
27 ABDOMINAL WALL INFECTION 2 0.0149
28 TRICHOGLOSSIA 6 0.0146
29 DISSEMINATED TRICHOSPORONOSIS 1 0.0139
30 ENTEROCOCCUS TEST POSITIVE 9 0.0139
31 ABDOMINAL WALL DISORDER 4 0.0137
32 DISSEMINATED HERPES SIMPLEX 1 0.0135
33 NEUTROPHIL TOXIC GRANULATION PRESENT 2 0.0132
34 ADAMS-STOKES SYNDROME 2 0.0130
35 ACQUIRED TRACHEO-OESOPHAGEAL FISTULA 1 0.0127
36 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 6 0.0117
37 BULBAR PALSY 3 0.0108
38 MYCOBACTERIUM FORTUITUM INFECTION 2 0.0108
39 BONE TUBERCULOSIS 4 0.0104
40 CHRONIC HEPATITIS C 4 0.0101
41 CONVULSIONS LOCAL 2 0.0101
42 ACINETOBACTER INFECTION 11 0.0100
43 TRICHOSPORON INFECTION 4 0.0099
44 SODIUM RETENTION 2 0.0098
45 BLADDER OBSTRUCTION 5 0.0097
46 OSMOTIC DEMYELINATION SYNDROME 7 0.0095
47 CRYSTALLURIA 5 0.0092
48 ACQUIRED FACTOR V DEFICIENCY 1 0.0091
49 OSTEORADIONECROSIS 2 0.0090
50 PATHOGEN RESISTANCE 81 0.0089
51 CEREBRAL NOCARDIOSIS 2 0.0086
52 RED BLOOD CELLS URINE POSITIVE 8 0.0083
53 CROSS SENSITIVITY REACTION 8 0.0082
54 MYCOBACTERIUM CHELONAE INFECTION 6 0.0081
55 INCISION SITE PAIN 9 0.0077
56 FEVER NEONATAL 1 0.0076
57 BRIEF RESOLVED UNEXPLAINED EVENT 1 0.0076
58 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 3 0.0074
59 DEJA VU 2 0.0073
60 POIKILOCYTOSIS 2 0.0072
61 CARDIAC SEPTAL HYPERTROPHY 2 0.0072
62 ATYPICAL MYCOBACTERIAL PNEUMONIA 1 0.0072
63 CYSTIC LUNG DISEASE 1 0.0070
64 NOCARDIOSIS 18 0.0070
65 MEGACOLON 11 0.0070
66 CARBON MONOXIDE POISONING 3 0.0070
67 BACTERIAL ABDOMINAL INFECTION 1 0.0068
68 POLYCHROMASIA 2 0.0067
69 ALLERGIC TRANSFUSION REACTION 1 0.0066
70 OTOTOXICITY 12 0.0065
71 URAEMIC ENCEPHALOPATHY 2 0.0064
72 METAPNEUMOVIRUS INFECTION 5 0.0064
73 CNS VENTRICULITIS 2 0.0061
74 SOFT TISSUE INFLAMMATION 2 0.0059
75 CUBITAL TUNNEL SYNDROME 2 0.0059
76 DEAFNESS NEUROSENSORY 19 0.0058
77 ABSCESS FUNGAL 1 0.0057
78 BASE EXCESS DECREASED 1 0.0056
79 KLEBSIELLA INFECTION 28 0.0055
80 CEREBRAL MASS EFFECT 2 0.0055
81 SKIN TEST POSITIVE 5 0.0054
82 ACINETOBACTER TEST POSITIVE 1 0.0052
83 ENCOPRESIS 1 0.0052
84 GRANULOCYTOSIS 1 0.0051
85 DEAFNESS PERMANENT 1 0.0051
86 HEPATITIS C VIRUS TEST POSITIVE 3 0.0051
87 GRANULOCYTE COUNT INCREASED 2 0.0049
88 OROPHARYNGEAL PLAQUE 2 0.0049
89 PSEUDOMEMBRANOUS COLITIS 11 0.0049
90 BURN INFECTION 1 0.0049
91 DYSBACTERIOSIS 1 0.0047
92 STAPHYLOCOCCAL ABSCESS 3 0.0047
93 EOSINOPHILIC PNEUMONIA ACUTE 4 0.0046
94 CLOSTRIDIUM TEST POSITIVE 10 0.0045
95 MULTIPLE-DRUG RESISTANCE 14 0.0045
96 EPILEPTIC ENCEPHALOPATHY 1 0.0045
97 THERAPEUTIC PRODUCT CROSS-REACTIVITY 4 0.0045
98 TOOTH IMPACTED 2 0.0043
99 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 2 0.0043
100 CRANIAL NERVE PARALYSIS 2 0.0042
101 PROTEUS INFECTION 3 0.0042
102 APLASIA 8 0.0041
103 ENTEROBACTER TEST POSITIVE 1 0.0041
104 PNEUMONIA KLEBSIELLA 7 0.0038
105 ASPARTATE AMINOTRANSFERASE DECREASED 2 0.0038
106 CHOLANGITIS INFECTIVE 1 0.0038
107 ANTIPHOSPHOLIPID SYNDROME 6 0.0037
108 TYPE IV HYPERSENSITIVITY REACTION 10 0.0036
109 PULMONARY NOCARDIOSIS 3 0.0036
110 MENINGITIS TUBERCULOUS 2 0.0036
111 BONE FRAGMENTATION 2 0.0036
112 AGITATED DEPRESSION 1 0.0035
113 PNEUMOCOCCAL INFECTION 2 0.0034
114 DEVICE COMPUTER ISSUE 1 0.0033
115 ENTEROCOCCAL INFECTION 16 0.0033
116 ENTEROBACTER BACTERAEMIA 1 0.0033
117 ERYTHROPENIA 1 0.0033
118 CREATININE URINE INCREASED 1 0.0033
119 CORNEA VERTICILLATA 1 0.0033
120 EXTENSOR PLANTAR RESPONSE 3 0.0033
121 GASTROENTERITIS ROTAVIRUS 1 0.0032
122 RASH MORBILLIFORM 9 0.0032
123 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 1 0.0032
124 CONGENITAL APLASIA 1 0.0032
125 FUNGAEMIA 5 0.0032
126 DERMATITIS EXFOLIATIVE GENERALISED 11 0.0032
127 KLEBSIELLA TEST POSITIVE 2 0.0031
128 ANISOCYTOSIS 2 0.0030
129 LINEAR IGA DISEASE 5 0.0030
130 SKIN OEDEMA 3 0.0030
131 ALCOHOL POISONING 8 0.0030
132 BLOOD TRIGLYCERIDES DECREASED 1 0.0030
133 GAS GANGRENE 1 0.0029
134 ANION GAP DECREASED 1 0.0029
135 FOETAL HYPOKINESIA 2 0.0029
136 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
137 DELAYED GRAFT FUNCTION 2 0.0028
138 BACTERIAL DISEASE CARRIER 2 0.0027
139 GENERALISED BULLOUS FIXED DRUG ERUPTION 1 0.0027
140 BRONCHOPLEURAL FISTULA 1 0.0027
141 GINGIVAL ULCERATION 2 0.0027
142 HEPATITIS CHOLESTATIC 16 0.0027
143 ACUTE PHASE REACTION 1 0.0026
144 DIAPHRAGMATIC DISORDER 2 0.0026
145 CEREBRAL ARTERIOSCLEROSIS 1 0.0026
146 COAGULATION TIME PROLONGED 4 0.0026
147 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 20 0.0026
148 HYPOALBUMINAEMIA 20 0.0026
149 CONVULSIVE THRESHOLD LOWERED 1 0.0025
150 METABOLIC ALKALOSIS 4 0.0025
151 SKIN BACTERIAL INFECTION 2 0.0025
152 EXCESSIVE GRANULATION TISSUE 2 0.0025
153 DELIRIUM TREMENS 1 0.0025
154 CONJUNCTIVITIS INFECTIVE 1 0.0025
155 PENILE HAEMORRHAGE 2 0.0025
156 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 12 0.0024
157 CANDIDA TEST POSITIVE 1 0.0024
158 WOUND DEHISCENCE 8 0.0024
159 GLUCOCORTICOID DEFICIENCY 1 0.0024
160 CLOSTRIDIAL INFECTION 8 0.0024
161 GLIOSIS 1 0.0023
162 AORTIC ARTERIOSCLEROSIS 6 0.0023
163 LUNG HYPERINFLATION 2 0.0023
164 ENCEPHALITIS CYTOMEGALOVIRUS 1 0.0023
165 PERIPHERAL NERVE INJURY 2 0.0023
166 GUILLAIN-BARRE SYNDROME 11 0.0023
167 CANDIDA SEPSIS 2 0.0022
168 HYPERPLASIA 2 0.0022
169 HYPERTRIGLYCERIDAEMIA 13 0.0022
170 STENOTROPHOMONAS INFECTION 3 0.0022
171 PRIMARY SEQUESTRUM 2 0.0022
172 PROTEIN URINE PRESENT 11 0.0022
173 TOXIC SKIN ERUPTION 22 0.0022
174 PNEUMOPERITONEUM 4 0.0022
175 CEREBRAL TOXOPLASMOSIS 2 0.0021
176 ANAPHYLACTOID SHOCK 1 0.0021
177 TONIC CONVULSION 3 0.0021
178 BLOOD BICARBONATE INCREASED 1 0.0021
179 BLAST CELLS PRESENT 1 0.0021
180 BONE SWELLING 2 0.0021
181 BLOOD URIC ACID DECREASED 1 0.0021
182 MASTOIDITIS 2 0.0020
183 ELECTROLYTE DEPLETION 1 0.0020
184 ENCEPHALITIS HERPES 1 0.0020
185 PYURIA 2 0.0020
186 INFLAMMATORY MARKER INCREASED 10 0.0020
187 HIGH DENSITY LIPOPROTEIN INCREASED 2 0.0020
188 INFECTIOUS PLEURAL EFFUSION 3 0.0020
189 ABDOMINAL INFECTION 5 0.0020
190 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 3 0.0020
191 POSTICTAL STATE 2 0.0019
192 OEDEMA MUCOSAL 2 0.0019
193 POLYOMAVIRUS VIRAEMIA 2 0.0019
194 HYPERLACTACIDAEMIA 5 0.0019
195 ENZYME ABNORMALITY 1 0.0019
196 TOXOPLASMOSIS 2 0.0019
197 BURSITIS INFECTIVE 1 0.0018
198 ELECTROCARDIOGRAM QT PROLONGED 66 0.0018
199 ESCHERICHIA INFECTION 15 0.0018
200 SYSTEMIC INFECTION 3 0.0018
201 LISTERIOSIS 2 0.0018
202 QUADRIPARESIS 3 0.0018
203 BLOOD PH INCREASED 1 0.0018
204 ENTEROBACTER INFECTION 3 0.0018
205 TOXIC ENCEPHALOPATHY 9 0.0018
206 BACTERIURIA 1 0.0018
207 DEAFNESS BILATERAL 3 0.0018
208 DRUG RESISTANCE 45 0.0018
209 HAEMATOMA INFECTION 1 0.0017
210 PROCALCITONIN INCREASED 2 0.0017
211 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
212 PNEUMOMEDIASTINUM 3 0.0017
213 PULMONARY TUBERCULOSIS 7 0.0016
214 VESTIBULAR DISORDER 2 0.0016
215 PSEUDOMONAS INFECTION 14 0.0016
216 BILIARY TRACT INFECTION 1 0.0016
217 HYPERNATRAEMIA 8 0.0016
218 DERMATITIS EXFOLIATIVE 8 0.0016
219 BLOOD CREATININE DECREASED 5 0.0016
220 SEROMA 2 0.0016
221 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
222 POSTOPERATIVE WOUND COMPLICATION 2 0.0016
223 SINUS ARRHYTHMIA 2 0.0015
224 C-REACTIVE PROTEIN DECREASED 1 0.0015
225 CELL DEATH 3 0.0015
226 NEUTROPHIL COUNT INCREASED 15 0.0015
227 ANASTOMOTIC LEAK 1 0.0014
228 LUNG ABSCESS 3 0.0014
229 RENAL TUBULAR DISORDER 4 0.0014
230 GRANULOMATOUS LIVER DISEASE 1 0.0014
231 BRONCHIAL WALL THICKENING 1 0.0014
232 SPONDYLITIS 5 0.0014
233 EPILEPSY 42 0.0014
234 HENOCH-SCHONLEIN PURPURA 3 0.0014
235 ENTEROCOLITIS HAEMORRHAGIC 2 0.0014
236 RASH MACULO-PAPULAR 30 0.0013
237 CHOLESTATIC LIVER INJURY 3 0.0013
238 BRAIN HERNIATION 4 0.0013
239 NEPHROPATHY TOXIC 15 0.0013
240 BRAIN STEM SYNDROME 1 0.0013
241 HIV INFECTION 4 0.0013
242 ASTIGMATISM 2 0.0013
243 COMPLICATION OF PREGNANCY 1 0.0013
244 MYOGLOBIN BLOOD INCREASED 2 0.0013
245 MULTIPLE ORGAN DYSFUNCTION SYNDROME 37 0.0013
246 PNEUMONIA PSEUDOMONAL 2 0.0013
247 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
248 PRODUCT DEPOSIT 2 0.0013
249 BILIRUBIN CONJUGATED INCREASED 3 0.0013
250 ENDOCARDITIS BACTERIAL 1 0.0013
251 SEPTIC SHOCK 55 0.0013
252 BLOOD ALBUMIN DECREASED 10 0.0013
253 DYSBIOSIS 1 0.0012
254 FUNGAL SEPSIS 1 0.0012
255 CARDIAC FAILURE ACUTE 8 0.0012
256 SYSTEMIC CANDIDA 3 0.0012
257 SPINAL DEFORMITY 2 0.0012
258 BRAIN ABSCESS 3 0.0012
259 DISSEMINATED TUBERCULOSIS 3 0.0012
260 BLOOD CHLORIDE INCREASED 2 0.0012
261 GINGIVAL ERYTHEMA 1 0.0012
262 TREATMENT DELAYED 2 0.0012
263 GASTROINTESTINAL NEOPLASM 1 0.0012
264 HEPATITIS TOXIC 3 0.0012
265 AXONAL NEUROPATHY 1 0.0011
266 ENTEROCUTANEOUS FISTULA 1 0.0011
267 KYPHOSIS 2 0.0011
268 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 29 0.0011
269 BLOOD ALBUMIN INCREASED 1 0.0011
270 PARAPARESIS 2 0.0011
271 HEPATOTOXICITY 25 0.0011
272 MONOPARESIS 2 0.0011
273 SOFT TISSUE INFECTION 2 0.0011
274 DISORGANISED SPEECH 2 0.0011
275 EOSINOPHILIA 19 0.0011
276 WOUND HAEMORRHAGE 4 0.0011
277 LYMPHOCYTE COUNT DECREASED 19 0.0011
278 ANAL HAEMORRHAGE 3 0.0011
279 ENDOTRACHEAL INTUBATION 3 0.0011
280 TOXIC EPIDERMAL NECROLYSIS 16 0.0011
281 DRUG DISPENSED TO WRONG PATIENT 1 0.0010
282 GINGIVAL RECESSION 2 0.0010
283 CLOSTRIDIUM DIFFICILE COLITIS 11 0.0010
284 DYSPNOEA AT REST 3 0.0010
285 ADENOVIRUS INFECTION 3 0.0010
286 CARDIOPULMONARY FAILURE 4 0.0010
287 WOUND SECRETION 4 0.0010
288 BLOOD UREA INCREASED 17 0.0010
289 LARGE INTESTINE PERFORATION 7 0.0010
290 EMPYEMA 2 0.0010
291 DEVICE RELATED SEPSIS 2 0.0010
292 PORTAL HYPERTENSION 3 0.0010
293 CHOLANGITIS 6 0.0010
294 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
295 SUBILEUS 2 0.0010
296 PHARYNGEAL ERYTHEMA 2 0.0009
297 SPUTUM INCREASED 2 0.0009
298 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0009
299 EXPOSED BONE IN JAW 2 0.0009
300 MYOCLONUS 11 0.0009
301 CLAUSTROPHOBIA 1 0.0009
302 TIC 5 0.0009
303 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
304 DEAFNESS UNILATERAL 5 0.0009
305 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
306 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
307 EPSTEIN-BARR VIRAEMIA 1 0.0009
308 CYTOMEGALOVIRUS INFECTION 15 0.0009
309 TORSADE DE POINTES 7 0.0009
310 SUSPECTED OFF LABEL USE 4 0.0009
311 GASTRIC POLYPS 2 0.0009
312 PERONEAL NERVE PALSY 5 0.0009
313 BLOOD FIBRINOGEN DECREASED 1 0.0009
314 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
315 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
316 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
317 CLOSTRIDIUM DIFFICILE INFECTION 19 0.0009
318 METASTATIC MALIGNANT MELANOMA 2 0.0009
319 HYPOPNOEA 3 0.0009
320 METHAEMOGLOBINAEMIA 2 0.0009
321 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
322 PATELLA FRACTURE 2 0.0009
323 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 2 0.0009
324 ESCHERICHIA TEST POSITIVE 1 0.0008
325 DERMATITIS BULLOUS 6 0.0008
326 DRUG-INDUCED LIVER INJURY 26 0.0008
327 CLOSTRIDIUM COLITIS 1 0.0008
328 PARADOXICAL DRUG REACTION 3 0.0008
329 AGRANULOCYTOSIS 15 0.0008
330 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
331 ABORTION MISSED 1 0.0008
332 APPENDICITIS PERFORATED 2 0.0008
333 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
334 ENDOCARDITIS 4 0.0008
335 ASPERGILLUS INFECTION 5 0.0008
336 EXFOLIATIVE RASH 2 0.0008
337 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
338 ANIMAL BITE 2 0.0007
339 BONE MARROW FAILURE 15 0.0007
340 DRUG SPECIFIC ANTIBODY 1 0.0007
341 EOSINOPHIL COUNT INCREASED 6 0.0007
342 HYPERTRANSAMINASAEMIA 5 0.0007
343 LUNG CONSOLIDATION 2 0.0007
344 DEVICE RELATED INFECTION 11 0.0007
345 BRONCHIAL OBSTRUCTION 1 0.0007
346 HYPERPYREXIA 3 0.0007
347 OXYGEN SATURATION ABNORMAL 2 0.0007
348 FACIAL PARALYSIS 6 0.0007
349 PURULENT DISCHARGE 3 0.0007
350 GENITAL RASH 1 0.0007
351 NEUROLOGICAL SYMPTOM 4 0.0007
352 RESPIRATORY FAILURE 51 0.0007
353 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
354 NEUROTOXICITY 12 0.0007
355 TOOTH DISCOLOURATION 2 0.0007
356 GINGIVAL SWELLING 3 0.0007
357 PURPURA 6 0.0007
358 GENITAL PAIN 1 0.0007
359 HEPATITIS FULMINANT 2 0.0007
360 BACTERAEMIA 8 0.0007
361 CHOLANGIOCARCINOMA 1 0.0007
362 METABOLIC ENCEPHALOPATHY 2 0.0007
363 MIXED LIVER INJURY 2 0.0007
364 DUODENITIS 2 0.0007
365 ENCEPHALOPATHY 16 0.0007
366 CALCULUS URINARY 1 0.0006
367 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
368 OLIGURIA 4 0.0006
369 BRONCHIAL DISORDER 1 0.0006
370 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
371 PULMONARY HAEMORRHAGE 5 0.0006
372 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
373 TRICUSPID VALVE INCOMPETENCE 5 0.0006
374 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
375 CARDIOGENIC SHOCK 9 0.0006
376 THROMBOCYTOPENIA 70 0.0006
377 SUBCUTANEOUS ABSCESS 3 0.0006
378 WHITE BLOOD CELL COUNT INCREASED 24 0.0006
379 PORTAL VEIN THROMBOSIS 2 0.0006
380 PLASMA CELL MYELOMA RECURRENT 2 0.0006
381 CRYPTOCOCCOSIS 1 0.0006
382 PLATELET COUNT INCREASED 8 0.0006
383 STAPHYLOCOCCAL SEPSIS 3 0.0006
384 BLOOD CALCIUM ABNORMAL 1 0.0006
385 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
386 POTENTIATING DRUG INTERACTION 2 0.0006
387 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
388 CANDIDA INFECTION 10 0.0006
389 ENTERITIS INFECTIOUS 1 0.0006
390 GAZE PALSY 1 0.0006
391 BLOOD PH DECREASED 1 0.0006
392 HYPOKALAEMIA 27 0.0006
393 HYPOCALCAEMIA 11 0.0006
394 TRISMUS 3 0.0006
395 CHOREA 1 0.0006
396 BLOOD MAGNESIUM DECREASED 5 0.0006
397 PARTIAL SEIZURES 3 0.0006
398 GASTROINTESTINAL OEDEMA 1 0.0006
399 LYMPHOPENIA 8 0.0006
400 DRUG ERUPTION 10 0.0006
401 MACULOPATHY 2 0.0006
402 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
403 BONE LESION 2 0.0006
404 CUTANEOUS VASCULITIS 2 0.0005
405 STAPHYLOCOCCAL INFECTION 18 0.0005
406 PNEUMONIA BACTERIAL 5 0.0005
407 LEUKOPENIA 27 0.0005
408 CATHETER PLACEMENT 1 0.0005
409 NECROSIS 3 0.0005
410 MALNUTRITION 6 0.0005
411 HEPATIC FUNCTION ABNORMAL 20 0.0005
412 BLADDER SPASM 1 0.0005
413 HYPERTHERMIA 4 0.0005
414 CHOLESTASIS 10 0.0005
415 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
416 BICYTOPENIA 1 0.0005
417 VENOUS THROMBOSIS 2 0.0005
418 PROSTATOMEGALY 2 0.0005
419 INCORRECT PRODUCT ADMINISTRATION DURATION 11 0.0005
420 PLEURISY 3 0.0005
421 PROTHROMBIN TIME PROLONGED 3 0.0005
422 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
423 SKIN PAPILLOMA 2 0.0005
424 LEUKOCYTOSIS 9 0.0005
425 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
426 FOAMING AT MOUTH 1 0.0005
427 EAR HAEMORRHAGE 1 0.0005
428 DEVICE DEPOSIT ISSUE 1 0.0005
429 DELIRIUM 17 0.0005
430 POLYURIA 4 0.0005
431 ARTHRITIS BACTERIAL 2 0.0005
432 ANAPHYLACTOID REACTION 2 0.0005
433 BACTERIAL INFECTION 9 0.0005
434 VENTRICULAR EXTRASYSTOLES 5 0.0005
435 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
436 TREATMENT FAILURE 39 0.0005
437 FEBRILE BONE MARROW APLASIA 2 0.0005
438 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
439 CARDIAC FAILURE CHRONIC 2 0.0005
440 ABSCESS INTESTINAL 1 0.0005
441 POOR QUALITY DRUG ADMINISTERED 3 0.0005
442 MULTI-ORGAN FAILURE 8 0.0005
443 PULMONARY FUNCTION TEST DECREASED 2 0.0005
444 CEREBELLAR SYNDROME 1 0.0005
445 ORAL CANDIDIASIS 6 0.0005
446 DIABETIC NEPHROPATHY 1 0.0005
447 LIGAMENT RUPTURE 2 0.0005
448 ABDOMINAL ABSCESS 2 0.0005
449 PHYSICAL DISABILITY 2 0.0005
450 SEPSIS 50 0.0004
451 LIVER INJURY 11 0.0004
452 PANCREATITIS ACUTE 10 0.0004
453 CHRONIC GASTRITIS 1 0.0004
454 STATUS EPILEPTICUS 5 0.0004
455 OSTEOMYELITIS 8 0.0004
456 PNEUMOTHORAX 7 0.0004
457 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
458 HAEMATOCRIT INCREASED 1 0.0004
459 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
460 CYTOMEGALOVIRUS COLITIS 1 0.0004
461 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
462 HEPATITIS 11 0.0004
463 HEPATIC ENCEPHALOPATHY 4 0.0004
464 ESCHERICHIA BACTERAEMIA 1 0.0004
465 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
466 SPINAL COLUMN STENOSIS 2 0.0004
467 HEPATOCELLULAR INJURY 6 0.0004
468 SKIN ABRASION 2 0.0004
469 PLATELET COUNT DECREASED 45 0.0004
470 COAGULOPATHY 7 0.0004
471 KIDNEY TRANSPLANT REJECTION 2 0.0004
472 SEROTONIN SYNDROME 8 0.0004
473 DIABETES INSIPIDUS 1 0.0004
474 GASTROENTERITIS 6 0.0004
475 INCORRECT DOSAGE ADMINISTERED 2 0.0004
476 PANCREATIC DISORDER 2 0.0004
477 BREATH SOUNDS ABNORMAL 2 0.0004
478 STEVENS-JOHNSON SYNDROME 9 0.0004
479 GENERALISED OEDEMA 5 0.0004
480 HYDRONEPHROSIS 3 0.0004
481 HAEMOGLOBIN DECREASED 41 0.0004
482 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
483 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
484 BRAIN OEDEMA 5 0.0004
485 DYSPHORIA 2 0.0004
486 HYPOTHERMIA 4 0.0004
487 HAEMOPTYSIS 11 0.0004
488 BODY TEMPERATURE INCREASED 8 0.0004
489 HYPERBILIRUBINAEMIA 4 0.0004
490 SKIN NECROSIS 2 0.0004
491 PETECHIAE 4 0.0004
492 MOUTH ULCERATION 8 0.0004
493 PREMATURE DELIVERY 6 0.0004
494 PANCYTOPENIA 21 0.0004
495 AREFLEXIA 1 0.0004
496 ALCOHOL ABUSE 1 0.0004
497 GASTROINTESTINAL INJURY 1 0.0004
498 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
499 HYDROCEPHALUS 2 0.0004
500 GASTRIC PERFORATION 1 0.0004
501 DRUG LEVEL INCREASED 6 0.0004
502 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
503 HEMIPLEGIA 3 0.0004
504 CHOLECYSTITIS INFECTIVE 1 0.0004
505 TRANSAMINASES INCREASED 8 0.0004
506 ACUTE PULMONARY OEDEMA 2 0.0004
507 MITRAL VALVE INCOMPETENCE 4 0.0004
508 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
509 CARDIAC MURMUR 3 0.0003
510 ESCHERICHIA SEPSIS 1 0.0003
511 MUCOSAL INFLAMMATION 9 0.0003
512 URINE OUTPUT DECREASED 3 0.0003
513 GASTROINTESTINAL NECROSIS 1 0.0003
514 ALANINE AMINOTRANSFERASE INCREASED 21 0.0003
515 ASPARTATE AMINOTRANSFERASE INCREASED 18 0.0003
516 ATAXIA 4 0.0003
517 NEUROPATHY PERIPHERAL 32 0.0003
518 ATYPICAL PNEUMONIA 1 0.0003
519 BLOOD CULTURE POSITIVE 1 0.0003
520 THERAPY NON-RESPONDER 15 0.0003
521 BLOOD BILIRUBIN INCREASED 9 0.0003
522 FEBRILE NEUTROPENIA 22 0.0003
523 HEPATITIS C 4 0.0003
524 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
525 CYTOPENIA 4 0.0003
526 GRAND MAL CONVULSION 3 0.0003
527 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
528 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
529 ANAEMIA 61 0.0003
530 HEPATIC CIRRHOSIS 6 0.0003
531 PRODUCT USE IN UNAPPROVED INDICATION 78 0.0003
532 BILE DUCT STONE 1 0.0003
533 METABOLIC ACIDOSIS 10 0.0003
534 ACUTE RESPIRATORY FAILURE 6 0.0003
535 CUSHINGOID 1 0.0003
536 NEUTROPENIA 42 0.0003
537 BACTERIAL SEPSIS 1 0.0003
538 DEAFNESS 8 0.0003
539 HYPOGAMMAGLOBULINAEMIA 2 0.0003
540 MUSCLE TWITCHING 7 0.0003
541 HYPOACUSIS 13 0.0003
542 ACUTE KIDNEY INJURY 46 0.0003
543 FUNGAL INFECTION 10 0.0003
544 CHOLECYSTITIS CHRONIC 2 0.0003
545 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
546 EMPHYSEMA 3 0.0003
547 PERITONITIS BACTERIAL 3 0.0003
548 BRONCHIECTASIS 2 0.0003
549 BK VIRUS INFECTION 1 0.0003
550 B-CELL LYMPHOMA 1 0.0003
551 SEIZURE 34 0.0003
552 TACHYPNOEA 4 0.0003
553 EYE MOVEMENT DISORDER 2 0.0003
554 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
555 DRUG INTERACTION 46 0.0003
556 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
557 GRANULOMA 1 0.0003
558 ERYTHEMA NODOSUM 1 0.0003
559 HYPOXIA 10 0.0003
560 DUODENAL ULCER 2 0.0003
561 DIVERTICULUM 2 0.0003
562 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
563 BRONCHOSPASM 4 0.0003
564 MENTAL DISORDER 12 0.0003
565 LIVER FUNCTION TEST ABNORMAL 8 0.0003
566 C-REACTIVE PROTEIN INCREASED 10 0.0003
567 RASH PUSTULAR 2 0.0003
568 HEPATIC FAILURE 8 0.0003
569 BLOOD SODIUM DECREASED 5 0.0003
570 HAEMODYNAMIC INSTABILITY 2 0.0003
571 ACIDOSIS 2 0.0003
572 TINNITUS 12 0.0003
573 ELECTROLYTE IMBALANCE 3 0.0003
574 APNOEA 2 0.0003
575 NERVOUS SYSTEM DISORDER 8 0.0003
576 PROCEDURAL PAIN 7 0.0003
577 LOW BIRTH WEIGHT BABY 2 0.0003
578 PYREXIA 87 0.0003
579 CEREBRAL ATROPHY 1 0.0003
580 ABSCESS 4 0.0003
581 POLYNEUROPATHY 3 0.0003
582 RENAL IMPAIRMENT 21 0.0002
583 MYELOSUPPRESSION 9 0.0002
584 FUNGAL SKIN INFECTION 1 0.0002
585 NO THERAPEUTIC RESPONSE 3 0.0002
586 ABNORMAL FAECES 2 0.0002
587 SPINAL COMPRESSION FRACTURE 2 0.0002
588 INFECTION 35 0.0002
589 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
590 FACE OEDEMA 4 0.0002
591 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
592 HEPATIC CYTOLYSIS 3 0.0002
593 CIRCULATORY COLLAPSE 4 0.0002
594 ABSCESS LIMB 1 0.0002
595 BLOOD POTASSIUM DECREASED 7 0.0002
596 UNRESPONSIVE TO STIMULI 6 0.0002
597 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
598 MELAENA 5 0.0002
599 LUNG INFILTRATION 2 0.0002
600 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
601 BLOOD CREATINE INCREASED 1 0.0002
602 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
603 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
604 GENERAL PHYSICAL HEALTH DETERIORATION 26 0.0002
605 JOINT RANGE OF MOTION DECREASED 3 0.0002
606 HAEMOLYTIC ANAEMIA 2 0.0002
607 GASTROINTESTINAL INFECTION 2 0.0002
608 ANAL INCONTINENCE 2 0.0002
609 NEUTROPHIL COUNT DECREASED 9 0.0002
610 HEPATIC ENZYME INCREASED 15 0.0002
611 HAEMOGLOBIN INCREASED 1 0.0002
612 EXOSTOSIS 2 0.0002
613 DISEASE COMPLICATION 1 0.0002
614 EAR DISORDER 1 0.0002
615 ARTHRITIS INFECTIVE 1 0.0002
616 HYPOMAGNESAEMIA 3 0.0002
617 ERYTHEMA MULTIFORME 2 0.0002
618 BLOOD CREATININE INCREASED 14 0.0002
619 NEPHROPATHY 2 0.0002
620 DEFORMITY 2 0.0002
621 PLEURAL EFFUSION 13 0.0002
622 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
623 LACERATION 2 0.0002
624 SPINAL DISORDER 2 0.0002
625 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
626 HAEMATOTOXICITY 2 0.0002
627 GASTROINTESTINAL TOXICITY 1 0.0002
628 ATELECTASIS 2 0.0002
629 THROMBOTIC MICROANGIOPATHY 2 0.0002
630 LUNG DISORDER 10 0.0002
631 HEPATOMEGALY 2 0.0002
632 CARDIOMYOPATHY 3 0.0002
633 SINUS DISORDER 4 0.0002
634 PULMONARY MASS 3 0.0002
635 PNEUMONIA ASPIRATION 5 0.0002
636 BONE LOSS 3 0.0002
637 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
638 TOOTH ABSCESS 2 0.0002
639 EAR DISCOMFORT 2 0.0002
640 CACHEXIA 1 0.0002
641 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
642 LUNG INFECTION 3 0.0002
643 TENDERNESS 2 0.0002
644 APLASTIC ANAEMIA 1 0.0002
645 DERMATITIS 4 0.0002
646 SUDDEN DEATH 2 0.0002
647 RENAL FAILURE ACUTE 8 0.0002
648 CHILLS 22 0.0002
649 CONFUSIONAL STATE 30 0.0002
650 LACTIC ACIDOSIS 6 0.0002
651 BLOOD POTASSIUM INCREASED 3 0.0002
652 WHITE BLOOD CELL COUNT DECREASED 20 0.0002
653 TREATMENT NONCOMPLIANCE 10 0.0002
654 SKIN LESION 5 0.0002
655 AUTISM SPECTRUM DISORDER 1 0.0002
656 RESPIRATORY ARREST 5 0.0002
657 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
658 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
659 PULMONARY OEDEMA 8 0.0002
660 FISTULA 2 0.0002
661 BLOOD CALCIUM DECREASED 2 0.0002
662 HEMIPARESIS 3 0.0002
663 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
664 GENERALISED ERYTHEMA 1 0.0002
665 GRANULOCYTOPENIA 1 0.0002
666 DERMATITIS CONTACT 2 0.0002
667 CONDITION AGGRAVATED 53 0.0002
668 PERICARDIAL EFFUSION 4 0.0002
669 DRUG INEFFECTIVE 228 0.0002
670 EYELID OEDEMA 2 0.0002
671 BLOOD CHOLESTEROL INCREASED 8 0.0002
672 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
673 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
674 BRADYKINESIA 1 0.0002
675 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
676 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
677 RENAL INJURY 5 0.0002
678 CHOLECYSTITIS 2 0.0002
679 MACULAR DEGENERATION 2 0.0002
680 ENDOPHTHALMITIS 1 0.0002
681 GANGRENE 1 0.0002
682 DRUG INTOLERANCE 16 0.0002
683 CORONARY ARTERY DISEASE 5 0.0002
684 NEURALGIA 4 0.0002
685 FOETAL GROWTH RESTRICTION 1 0.0002
686 LOSS OF CONSCIOUSNESS 21 0.0002
687 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
688 ILEUS 2 0.0002
689 HAIR COLOUR CHANGES 2 0.0002
690 EPISTAXIS 12 0.0002
691 SECRETION DISCHARGE 2 0.0002
692 BLEPHAROSPASM 1 0.0002
693 CELLULITIS 8 0.0002
694 OFF LABEL USE 138 0.0002
695 CARDIAC ARREST 13 0.0002
696 SLEEP APNOEA SYNDROME 3 0.0002
697 ENTERITIS 1 0.0002
698 ANAPHYLACTIC SHOCK 4 0.0002
699 HAEMORRHOIDS 3 0.0002
700 GASTRITIS 4 0.0002
701 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
702 ABNORMAL BEHAVIOUR 6 0.0002
703 PANCREATITIS 8 0.0002
704 JAUNDICE 4 0.0001
705 COLITIS ISCHAEMIC 1 0.0001
706 UVEITIS 2 0.0001
707 DISEASE RECURRENCE 7 0.0001
708 GINGIVAL BLEEDING 2 0.0001
709 RASH ERYTHEMATOUS 7 0.0001
710 ECCHYMOSIS 1 0.0001
711 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
712 HAEMATOCHEZIA 8 0.0001
713 RESPIRATORY DISTRESS 4 0.0001
714 DROOLING 1 0.0001
715 ENCEPHALITIS 1 0.0001
716 MENTAL STATUS CHANGES 4 0.0001
717 RHABDOMYOLYSIS 6 0.0001
718 WOUND 4 0.0001
719 PNEUMONIA 46 0.0001
720 LYMPHADENOPATHY 5 0.0001
721 SINUS TACHYCARDIA 2 0.0001
722 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
723 FAECES DISCOLOURED 3 0.0001
724 VOMITING 65 0.0001
725 DECREASED APPETITE 32 0.0001
726 ASCITES 4 0.0001
727 LIVER DISORDER 6 0.0001
728 RASH PAPULAR 3 0.0001
729 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
730 COLITIS 5 0.0001
731 SHOCK 3 0.0001
732 HAEMOLYSIS 1 0.0001
733 OEDEMA 7 0.0001
734 EJECTION FRACTION DECREASED 2 0.0001
735 ACUTE MYELOID LEUKAEMIA 2 0.0001
736 PLASMA CELL MYELOMA 5 0.0001
737 GINGIVAL PAIN 1 0.0001
738 INTERSTITIAL LUNG DISEASE 6 0.0001
739 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
740 BACK DISORDER 2 0.0001
741 DECUBITUS ULCER 1 0.0001
742 CHOLELITHIASIS 4 0.0001
743 PHOTOSENSITIVITY REACTION 2 0.0001
744 EMBOLISM 1 0.0001
745 AGGRESSION 6 0.0001
746 GAIT INABILITY 4 0.0001
747 HAEMODIALYSIS 1 0.0001
748 DISEASE PROGRESSION 14 0.0001
749 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
750 ANURIA 1 0.0001
751 ORTHOSTATIC HYPOTENSION 2 0.0001
752 ECZEMA 6 0.0001
753 HYPOTENSION 23 0.0001
754 BLOOD CALCIUM INCREASED 1 0.0001
755 GROIN PAIN 1 0.0001
756 PNEUMONITIS 3 0.0001
757 GASTROINTESTINAL CARCINOMA 1 0.0001
758 RESTLESS LEGS SYNDROME 2 0.0001
759 BONE DISORDER 2 0.0001
760 HEPATIC STEATOSIS 2 0.0001
761 FLANK PAIN 1 0.0001
762 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
763 HYPONATRAEMIA 6 0.0001
764 DYSARTHRIA 4 0.0001
765 DYSPHAGIA 10 0.0001
766 BLOOD URINE PRESENT 2 0.0001
767 BLOOD PRESSURE DECREASED 7 0.0001
768 RED BLOOD CELL COUNT DECREASED 3 0.0001
769 HERNIA 2 0.0001
770 DIZZINESS POSTURAL 1 0.0001
771 TACHYCARDIA 9 0.0001
772 DISORIENTATION 4 0.0001
773 HAEMATOCRIT DECREASED 2 0.0001
774 BRAIN INJURY 1 0.0001
775 PREMATURE BABY 3 0.0001
776 APHASIA 3 0.0001
777 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
778 DRUG LEVEL DECREASED 1 0.0001
779 BLINDNESS 4 0.0001
780 RIB FRACTURE 2 0.0001
781 PERITONITIS 2 0.0001
782 EXPOSURE DURING PREGNANCY 6 0.0001
783 CARDIO-RESPIRATORY ARREST 4 0.0001
784 MUSCULOSKELETAL PAIN 5 0.0001
785 SKIN EXFOLIATION 8 0.0001
786 EATING DISORDER 2 0.0001
787 RETCHING 2 0.0001
788 POOR QUALITY SLEEP 2 0.0001
789 PRURITUS GENERALISED 2 0.0001
790 VISUAL ACUITY REDUCED 3 0.0001
791 DYSPNOEA 51 0.0001
792 ARTHROPATHY 5 0.0001
793 GLOSSODYNIA 2 0.0001
794 GASTROINTESTINAL DISORDER 8 0.0001
795 BLISTER 5 0.0001
796 HAEMATURIA 3 0.0001
797 NIGHTMARE 3 0.0001
798 HAEMORRHAGE 9 0.0001
799 CAESAREAN SECTION 1 0.0001
800 RENAL DISORDER 4 0.0001
801 PALPITATIONS 10 0.0001
802 RASH 37 0.0001
803 NAUSEA 67 0.0001
804 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
805 CEREBRAL HAEMORRHAGE 3 0.0001
806 STOMATITIS 5 0.0001
807 ADRENAL INSUFFICIENCY 1 0.0001
808 VERTIGO 5 0.0001
809 RESTLESSNESS 3 0.0001
810 DYSURIA 3 0.0001
811 OSTEONECROSIS OF JAW 2 0.0001
812 DIARRHOEA 52 0.0001
813 HALLUCINATION 6 0.0001
814 DERMATITIS ALLERGIC 1 0.0001
815 THERAPY CESSATION 4 0.0001
816 ERECTILE DYSFUNCTION 2 0.0001
817 INFLAMMATION 4 0.0001
818 SWELLING FACE 5 0.0001
819 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
820 ANKYLOSING SPONDYLITIS 1 0.0001
821 CHEST PAIN 14 0.0001
822 BRADYCARDIA 4 0.0001
823 EAR INFECTION 2 0.0001
824 DEHYDRATION 10 0.0001
825 COUGH 21 0.0001
826 DISTURBANCE IN ATTENTION 4 0.0001
827 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
828 PULMONARY EMBOLISM 7 0.0001
829 ACUTE HEPATIC FAILURE 1 0.0001
830 ABDOMINAL PAIN 17 0.0001
831 POLLAKIURIA 3 0.0001
832 PAIN IN JAW 2 0.0001
833 DIALYSIS 1 0.0001
834 MOBILITY DECREASED 5 0.0001
835 FLUID OVERLOAD 1 0.0001
836 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
837 ACUTE MYOCARDIAL INFARCTION 2 0.0001
838 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
839 WHEEZING 4 0.0001
840 HAEMORRHAGE INTRACRANIAL 1 0.0001
841 RESPIRATORY DISORDER 2 0.0001
842 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
843 CHRONIC KIDNEY DISEASE 5 0.0001
844 OEDEMA PERIPHERAL 8 0.0001
845 DIABETES MELLITUS 5 0.0001
846 DRUG DISPENSING ERROR 1 0.0001
847 URINARY TRACT INFECTION 11 0.0001
848 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
849 COMA 3 0.0001
850 CARDIAC FAILURE 5 0.0001
851 ATRIAL FIBRILLATION 6 0.0001
852 DEEP VEIN THROMBOSIS 4 0.0001
853 RENAL FAILURE 8 0.0001
854 SKIN DISORDER 2 0.0001
855 HYPERSENSITIVITY 11 0.0001
856 PRODUCT USE ISSUE 11 0.0001
857 NEOPLASM PROGRESSION 2 0.0001
858 SPEECH DISORDER 3 0.0001
859 RASH MACULAR 2 0.0001
860 HYPERKALAEMIA 2 0.0001
861 HYPERGLYCAEMIA 2 0.0001
862 PANIC ATTACK 2 0.0001
863 ANAPHYLACTIC REACTION 3 0.0001
864 BRONCHITIS 4 0.0001
865 WEIGHT DECREASED 15 0.0001
866 ERYTHEMA 11 0.0001
867 OXYGEN SATURATION DECREASED 3 0.0001
868 GASTRIC ULCER 1 0.0001
869 CONVULSION 3 0.0001
870 HERPES ZOSTER 3 0.0001
871 MYOCARDIAL INFARCTION 9 0.0001
872 CATARACT 3 0.0001
873 CYTOKINE RELEASE SYNDROME 1 0.0000
874 THROMBOSIS 4 0.0000
875 SOMNOLENCE 10 0.0000
876 FULL BLOOD COUNT DECREASED 1 0.0000
877 THERAPEUTIC RESPONSE DECREASED 3 0.0000
878 FEEDING DISORDER 1 0.0000
879 DYSKINESIA 2 0.0000
880 DISCOMFORT 3 0.0000
881 CHEST DISCOMFORT 5 0.0000
882 ABDOMINAL DISTENSION 5 0.0000
883 BLOOD GLUCOSE INCREASED 9 0.0000
884 OSTEOARTHRITIS 2 0.0000
885 RECTAL HAEMORRHAGE 2 0.0000
886 INFUSION RELATED REACTION 3 0.0000
887 ASTHENIA 17 0.0000
888 CHROMATURIA 1 0.0000
889 NEPHROLITHIASIS 2 0.0000
890 ADVERSE EVENT 4 0.0000
891 COGNITIVE DISORDER 2 0.0000
892 SLEEP DISORDER 3 0.0000
893 HYPERTENSION 9 0.0000
894 ARRHYTHMIA 2 0.0000
895 PRODUCTIVE COUGH 2 0.0000
896 URTICARIA 7 0.0000
897 OVERDOSE 9 0.0000
898 DIABETIC KETOACIDOSIS 1 0.0000
899 CONTUSION 4 0.0000
900 HYPOGLYCAEMIA 2 0.0000
901 CEREBRAL INFARCTION 1 0.0000
902 DYSGEUSIA 3 0.0000
903 EXTRAPYRAMIDAL DISORDER 1 0.0000
904 HYPOAESTHESIA 6 0.0000
905 GASTRIC CANCER 1 0.0000
906 HAEMATEMESIS 1 0.0000
907 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
908 SINUSITIS 4 0.0000
909 DIPLOPIA 1 0.0000
910 DEATH 33 0.0000
911 PARAESTHESIA 6 0.0000
912 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
913 FEAR 1 0.0000
914 CONSTIPATION 8 0.0000
915 MALAISE 16 0.0000
916 PRURITUS 14 0.0000
917 ABNORMAL DREAMS 1 0.0000
918 TREMOR 6 0.0000
919 MEDICATION ERROR 2 0.0000
920 TOXICITY TO VARIOUS AGENTS 6 0.0000
921 INCORRECT DOSE ADMINISTERED 8 0.0000
922 ANGINA PECTORIS 1 0.0000
923 LETHARGY 2 0.0000
924 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
925 BACK PAIN 8 0.0000
926 DYSPHONIA 2 0.0000
927 BONE PAIN 2 0.0000
928 ABDOMINAL PAIN UPPER 7 0.0000
929 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
930 BLOOD PRESSURE INCREASED 5 0.0000
931 VISUAL IMPAIRMENT 4 0.0000
932 CYSTITIS 1 0.0000
933 PAIN IN EXTREMITY 9 0.0000
934 EXPIRED PRODUCT ADMINISTERED 1 0.0000
935 SYNCOPE 3 0.0000
936 GASTRIC DISORDER 1 0.0000
937 BURNING SENSATION 2 0.0000
938 INJURY 2 0.0000
939 ANXIETY 8 0.0000
940 DIZZINESS 14 0.0000
941 THERAPY INTERRUPTED 2 0.0000
942 DRUG EFFECT INCOMPLETE 1 0.0000
943 UNDERDOSE 2 0.0000
944 MUSCLE SPASMS 5 0.0000
945 AGITATION 2 0.0000
946 DYSPNOEA EXERTIONAL 1 0.0000
947 DEPRESSION 6 0.0000
948 INSOMNIA 7 0.0000
949 ALOPECIA 5 0.0000
950 EMOTIONAL DISTRESS 3 0.0000
951 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
952 DRY MOUTH 2 0.0000
953 DEVICE LEAKAGE 1 0.0000
954 ANGIOEDEMA 1 0.0000
955 WEIGHT INCREASED 5 0.0000
956 OROPHARYNGEAL PAIN 2 0.0000
957 BLOOD GLUCOSE DECREASED 1 0.0000
958 HEART RATE INCREASED 2 0.0000
959 FLUSHING 2 0.0000
960 FLUID RETENTION 1 0.0000
961 HOSPITALISATION 3 0.0000
962 FATIGUE 15 0.0000
963 HEADACHE 12 0.0000
964 DEPRESSED MOOD 1 0.0000
965 INFLUENZA 2 0.0000
966 ABDOMINAL DISCOMFORT 3 0.0000
967 CEREBROVASCULAR ACCIDENT 3 0.0000
968 ASTHMA 2 0.0000
969 MYALGIA 3 0.0000
970 MUSCULAR WEAKNESS 2 0.0000
971 EYE IRRITATION 1 0.0000
972 ARTHRALGIA 7 0.0000
973 NO ADVERSE EVENT 3 0.0000
974 HYPERHIDROSIS 2 0.0000
975 AMNESIA 1 0.0000
976 VISION BLURRED 2 0.0000
977 PERIPHERAL SWELLING 2 0.0000
978 DRUG DOSE OMISSION BY DEVICE 1 0.0000
979 CARDIAC FAILURE CONGESTIVE 1 0.0000
980 COMPLETED SUICIDE 1 0.0000
981 BALANCE DISORDER 1 0.0000
982 DRUG WITHDRAWAL SYNDROME 1 0.0000
983 DEVICE ISSUE 1 0.0000
984 ADVERSE DRUG REACTION 1 0.0000
985 DYSPEPSIA 1 0.0000
986 PAIN 6 0.0000
987 PRODUCT DOSE OMISSION ISSUE 2 0.0000
988 GAIT DISTURBANCE 1 0.0000
989 FEELING ABNORMAL 1 0.0000
990 FALL 1 0.0000